Literature DB >> 9049331

Brefeldin A and monensin arrest cell surface expression of membrane glycoproteins and release of rubella virus.

Z Qiu1, F Tufaro, S Gillam.   

Abstract

The maturation of rubella virus (RV) glycoproteins E2 and E1 was examined by using brefeldin A (BFA) and monensin. BFA, which induces the rapid redistribution of Golgi enzymes residing in the Golgi complex into the endoplasmic reticulum (ER), was used to locate the intracellular site for the modification of carbohydrate side-chains on RV E1 and E2 proteins. The monovalent ionophore monensin, which inhibits intracellular transport of proteins through the ER-Golgi complex, was used to block the transport of E1 and E2 glycoproteins through the Golgi complex. BFA and monensin effectively blocked the cell surface expression of RV E2 and E1 proteins, secretion of an anchor-free form of E2 and budding of RV from the plasma membrane. For O-linked glycosylation, addition of N-acetylgalactosamine and galactose to E2 protein was found to take place in the medial to the trans Golgi. A dramatic change in the intracellular distribution of RV structural proteins was observed when transfected COS cells were treated with BFA or monensin, although the proteolytic processing of RV structural protein precursor was not affected. In the presence of BFA or monensin, virus release from infected Vero cells was only 0.1% of the intracellular virus, and the intracellular virus titre decreased as well. Our results suggest that O-linked glycosylation on the E2 protein occurred in the post-ER region and the transport of RV structural proteins to the Golgi complex and post-Golgi compartment may be a rate-limiting step in RV assembly and budding.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9049331     DOI: 10.1099/0022-1317-76-4-855

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Mutational analysis of glycosylation, membrane translocation, and cell surface expression of the hepatitis E virus ORF2 protein.

Authors:  M Zafrullah; M H Ozdener; R Kumar; S K Panda; S Jameel
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Intracellular localization of the PDE4A cAMP-specific phosphodiesterase splice variant RD1 (RNPDE4A1A) in stably transfected human thyroid carcinoma FTC cell lines.

Authors:  L Pooley; Y Shakur; G Rena; M D Houslay
Journal:  Biochem J       Date:  1997-01-01       Impact factor: 3.857

3.  Brefeldin A and Cytochalasin B reduce dengue virus replication in cell cultures but do not protect mice against viral challenge.

Authors:  Kleber Juvenal Silva Farias; Paula Renata Lima Machado; Renato Ferreira de Almeida Júnior; Benedito Antônio Lopes da Fonseca
Journal:  Access Microbiol       Date:  2019-07-22

4.  Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively.

Authors:  J M Mackenzie; E G Westaway
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

5.  Expression of the rubella virus structural proteins by an infectious Sindbis virus vector.

Authors:  J P Chen; D Miller; S Katow; T K Frey
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

6.  Intracellular processing, glycosylation, and cell surface expression of human metapneumovirus attachment glycoprotein.

Authors:  Li Liu; Nathalie Bastien; Yan Li
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

7.  Effects of mutations in the rubella virus E1 glycoprotein on E1-E2 interaction and membrane fusion activity.

Authors:  D Yang; D Hwang; Z Qiu; S Gillam
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

8.  Uptake of proteins and degradation of human serum albumin by Plasmodium falciparum-infected human erythrocytes.

Authors:  Ahmed El Tahir; Pawan Malhotra; Virander S Chauhan
Journal:  Malar J       Date:  2003-05-07       Impact factor: 2.979

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.